Skip to content

Low-Dose Lidocaine Infusion for Acute Pain Management Pilot Study

Low-Dose Lidocaine Infusion for Acute Pain Management in the Surgical Intensive Care Unit - A Pilot Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06725485
Enrollment
18
Registered
2024-12-10
Start date
2021-07-02
Completion date
2024-06-17
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Management

Brief summary

The purpose of this study is to evaluate the safety and efficacy of lidocaine infusion in acute pain management following open abdominal surgery, including opiate use after surgery and the incidence of postoperative nausea and vomiting, Ileus, length of stays (ICU/hospital), and improvement in patient satisfaction.

Detailed description

The management of acute pain remains challenging for the physicians, with many patients suffering from inadequate pain control following surgery. Evidence has shown that 90% of patients in the intensive care unit usually treated with opioids for pain. Poorly controlled pain and opioid-related adverse events have several negative consequences for critically ill patients during the postoperative period, including delay in functional recovery and hospital discharge, increased length of stay, development of chronic postsurgical pain, reduced patient satisfaction, and increased total healthcare cost. The reported incidence of postoperative Ileus varies with the procedure, ranging from 14.9% for large-bowel resection and 19.2% for small-bowel resection). Although many analgesic therapies are available, the high incidence of postoperative pain among patients indicates that there are still significant treatment challenges. Recently, there has been much interest in using low-dose lidocaine infusion for acute pain management in the operating room or/and PACU. Lidocaine is a drug with multiple effects, including anti-arrhythmic, local, topical, and injectable anesthetics. Lidocaine is also used for uncontrolled and chronic pain. However, this is an off-label use. Additionally, I.V. lidocaine is a potent anti-inflammatory, anti-hyperalgesic, and gastrointestinal pro-peristaltic drug. There is a lack of data on low dose lidocaine infusion for acute postoperative pain management in surgical critical care patients.

Interventions

DRUGLow-Dose Lidocaine

Low-dose lidocaine infusion 10-30 mcg/kg/min administered within 1 hour of ICU admission.

Sponsors

The Methodist Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males or females age \> 18 years admitted to surgical ICU. * Severe acute pain with pain scale \> 7, following open exploratory laparotomy for bowel, gall bladder, and pancreatic surgeries. * Women of childbearing age must have a negative urine/serum pregnancy test.

Exclusion criteria

* Regional anesthesia during surgery * Heart failure with ejection fraction \< 20%. * Allergy to amide local anesthetics * Neuraxial anesthesia during surgery * Post-liver transplant patients * Hemodynamically unstable patients on two or more vasopressors * Child-Pugh Class C or MELD \>20 * Any investigational drug use within 30 days before enrollment * Pregnant or lactating females * Patients with chronic opioid-dependence * Intubated and mechanically ventilated patients on intensive care unit analgo-sedation * Subjects who do not agree to participate or may be non-compliant with study schedules or procedures.

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption on post-operative day 3Post-operative day 3Opioid consumption in a 24-hour period starting 3 days after surgery, measured in morphine milligram equivalents

Secondary

MeasureTime frameDescription
Opioid-Free DaysTime of surgery through the end of post-operative day 3The proportion of days post-surgery that the patient did not require opioid analgesia
Time Until Return in bowel functionTime of surgery through discharge, up to 30 daysPost-operative day when patient first has a bowel movement
Pain Scale at 72 Hours Post-SurgeryPost-operative day 3Patient numeric pain scale rating (0-10), with 0 being no pain and 10 being the worst pain possible
Post-operative intensive care unit length of stayTime of surgery through intensive care unit discharge, up to 1 yearNumber of days between surgery and discharge from the intensive care unit after surgery
Post-operative hospital length of stayTime of surgery through hospital discharge, up to 1 yearNumber of days between surgery and discharge from hospital after surgery
Return to Oral FeedingTime of surgery through discharge, up to 30 daysPost-operative day number when patient returns to oral feeding

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026